We are live on ! Find out more
FIM

Fernwood Investment Management Portfolio holdings

AUM $288M
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+4.39%
1 Year Est. Return
+33.54%
3 Year Est. Return
+83.37%
5 Year Est. Return
+196.85%
10 Year Est. Return
+650.16%
AUM
$185M
AUM Growth
+$6.05M
Cap. Flow
+$225K
Cap. Flow %
0.12%
Top 10 Hldgs %
33.29%
Holding
163
New
18
Increased
27
Reduced
76
Closed
6

Sector Composition

Rank Sector Weight
1 Healthcare 29.16%
2 Energy 8.78%
3 Technology 6.05%
4 Consumer Discretionary 5.9%
5 Financials 5.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GBT
1
DELISTED
Global Blood Therapeutics, Inc.
GBT
$16.1M 8.69%
356,069
+560
+0.2% +$25.5K
MYOK
2
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$10.2M 5.5%
205,050
-74,623
-27% -$3.61M
PTLA
3
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$8.59M 4.64%
227,398
-1,475
-0.6% -$56.4K
IVV icon
4
iShares Core S&P 500 ETF
IVV
$878B
$5.45M 2.94%
19,952
-459
-2% -$125K
META icon
5
Meta Platforms (Facebook)
META
$1.42T
$4.48M 2.42%
23,076
-776
-3% -$140K
MO icon
6
Altria Group
MO
$114B
$4.08M 2.2%
71,819
+825
+1% +$47.6K
IYK icon
7
iShares US Consumer Staples ETF
IYK
$1.4B
$3.28M 1.77%
83,235
-2,550
-3% -$99.1K
DVY icon
8
iShares Select Dividend ETF
DVY
$23.5B
$3.24M 1.75%
33,149
-1,160
-3% -$113K
GILD icon
9
Gilead Sciences
GILD
$162B
$3.21M 1.73%
45,298
-1,345
-3% -$95K
IWM icon
10
iShares Russell 2000 ETF
IWM
$79.8B
$3.08M 1.66%
18,775
-39
-0.2% -$6.24K
CVS icon
11
CVS Health
CVS
$133B
$2.93M 1.58%
45,473
-900
-2% -$59.3K
V icon
12
Visa
V
$684B
$2.68M 1.45%
20,238
-329
-2% -$42.3K
IJH icon
13
iShares Core S&P Mid-Cap ETF
IJH
$122B
$2.65M 1.43%
67,955
-585
-0.9% -$22.6K
BIIB icon
14
Biogen
BIIB
$30B
$2.63M 1.42%
9,075
-100
-1% -$28.1K
PM icon
15
Philip Morris
PM
$297B
$2.52M 1.36%
31,266
+3,850
+14% +$327K
UNP icon
16
Union Pacific
UNP
$174B
$2.43M 1.31%
17,130
-930
-5% -$130K
IRM icon
17
Iron Mountain
IRM
$36.4B
$2.4M 1.3%
68,594
+990
+1% +$33.4K
IWB icon
18
iShares Russell 1000 ETF
IWB
$48.2B
$2.38M 1.28%
15,646
-698
-4% -$105K
GLNG icon
19
Golar LNG
GLNG
$5B
$2.38M 1.28%
80,650
+400
+0.5% +$12.1K
JNJ icon
20
Johnson & Johnson
JNJ
$618B
$2.15M 1.16%
17,698
-650
-4% -$81.1K
PSX icon
21
Phillips 66
PSX
$84.9B
$2.13M 1.15%
19,001
-950
-5% -$107K
AGIO icon
22
Agios Pharmaceuticals
AGIO
$1.79B
$2.12M 1.14%
25,150
TPL icon
23
Texas Pacific Land
TPL
$27.8B
$2.09M 1.13%
27,018
+1,800
+7% +$126K
GOOGL icon
24
Alphabet (Google) Class A
GOOGL
$4.36T
$2.06M 1.11%
36,520
+2,200
+6% +$120K
XOM icon
25
ExxonMobil
XOM
$644B
$2.01M 1.08%
24,260
+370
+2% +$29.5K

Similar funds

Fernwood Investment Management's Q2 2018 Portfolio in Review

As of Q2 2018, Fernwood Investment Management held 163 positions worth $185M, up 3.4% from $179M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Fernwood Investment Management's Q2 2018 filing shows 18 new, 27 increased, 76 reduced and 6 closed positions. Its largest new stake was Avaya Holdings Corp. Common Stock: 69,100 shares worth $1.39M. The largest sale was MyoKardia, Inc. Common Stock, an estimated $3.61M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 33% a quarter earlier, followed by Energy and Technology.

  • Fernwood Investment Management's largest Q2 2018 buy was Avaya Holdings Corp. Common Stock: 69,100 shares worth $1.39M.
  • Fernwood Investment Management added most to Amazon in Q2 2018, an estimated $376K increase.
  • Fernwood Investment Management's biggest Q2 2018 reduction was MyoKardia, Inc. Common Stock, cutting an estimated $3.61M.
  • Fernwood Investment Management fully exited iPath ETNs Linked to the MSCI India Total Return Index in Q2 2018, selling an estimated $752K.
  • Fernwood Investment Management's ten largest holdings make up 33% of its $185M portfolio in Q2 2018.
  • Fernwood Investment Management opened 18 new positions and closed 6 in Q2 2018.
  • Fernwood Investment Management's portfolio value rose 3.4% quarter-over-quarter to $185M.

Based on Fernwood Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.